WKYT | Lexington, Kentucky | News

FDA OKs first-of-a-kind diabetes drug from J&J

The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar.

MGN Online

WASHINGTON (AP) - The Food and Drug Administration says it has approved a first-of-a-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar.

The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects about 26 million Americans.

The drug is a once-a-day medicine designed to lower blood sugar levels in patients by eliminating more sugar in their urine. The drug works by blocking the reabsorption of sugar by the kidneys, which occurs at higher levels in patients with diabetes.

J&J has touted the drug as the first in a new class of medications to help address the nation's growing diabetes epidemic. The drug differs from older drugs that work by decreasing the amount of sugar absorbed from food and stored in the liver.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

WKYT

2851 Winchester Rd. Lexington, Ky 40509 859-299-0411 - switchboard 859-299-2727 - newsroom
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 200639521 - wkyt.com/a?a=200639521
Gray Television, Inc.